181 related articles for article (PubMed ID: 30353883)
1. Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications.
McKay MJ; Taubman KL; Foroudi F; Lee ST; Scott AM
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):783-791. PubMed ID: 30353883
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1.
Alongi P; Laudicella R; Desideri I; Chiaravalloti A; Borghetti P; Quartuccio N; Fiore M; Evangelista L; Marino L; Caobelli F; Tuscano C; Mapelli P; Lancellotta V; Annunziata S; Ricci M; Ciurlia E; Fiorentino A
Crit Rev Oncol Hematol; 2019 Aug; 140():74-79. PubMed ID: 30795884
[TBL] [Abstract][Full Text] [Related]
4. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
Ciernik IF; Dizendorf E; Baumert BG; Reiner B; Burger C; Davis JB; Lütolf UM; Steinert HC; Von Schulthess GK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):853-63. PubMed ID: 14529793
[TBL] [Abstract][Full Text] [Related]
5. The role of PET in target localization for radiotherapy treatment planning.
Rembielak A; Price P
Onkologie; 2008 Feb; 31(1-2):57-62. PubMed ID: 18268401
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature.
Sindoni A; Minutoli F; Pontoriero A; Iatì G; Baldari S; Pergolizzi S
Lung Cancer; 2016 Jun; 96():78-86. PubMed ID: 27133755
[TBL] [Abstract][Full Text] [Related]
7. Positron-emission tomography-guided radiation therapy: Ongoing projects and future hopes.
Giraud N; Popinat G; Regaieg H; Tonnelet D; Vera P
Cancer Radiother; 2020 Aug; 24(5):437-443. PubMed ID: 32247689
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography/computed tomography for target delineation in head and neck cancers.
Ahn PH; Garg MK
Semin Nucl Med; 2008 Mar; 38(2):141-8. PubMed ID: 18243850
[TBL] [Abstract][Full Text] [Related]
9. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
10. Delineation of lung cancer with FDG PET/CT during radiation therapy.
Ganem J; Thureau S; Gardin I; Modzelewski R; Hapdey S; Vera P
Radiat Oncol; 2018 Nov; 13(1):219. PubMed ID: 30419929
[TBL] [Abstract][Full Text] [Related]
11. PET/CT in Radiation Therapy Planning.
Specht L; Berthelsen AK
Semin Nucl Med; 2018 Jan; 48(1):67-75. PubMed ID: 29195619
[TBL] [Abstract][Full Text] [Related]
12. Impact of positron emission tomography with computed tomography for image-guided radiotherapy.
Isnardi V; Thureau S; Vera P
Cancer Radiother; 2020 Aug; 24(5):362-367. PubMed ID: 32284178
[TBL] [Abstract][Full Text] [Related]
13. Correlation between fluorodeoxyglucose hotspots on preradiotherapy PET/CT and areas of cancer local relapse: Systematic review of literature.
Abgral R; Bourhis D; Calais J; Lucia F; Leclère JC; Salaün PY; Vera P; Schick U
Cancer Radiother; 2020 Aug; 24(5):444-452. PubMed ID: 32620457
[TBL] [Abstract][Full Text] [Related]
14. Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.
Verma V; Choi JI; Sawant A; Gullapalli RP; Chen W; Alavi A; Simone CB
Semin Radiat Oncol; 2018 Jun; 28(3):171-177. PubMed ID: 29933876
[TBL] [Abstract][Full Text] [Related]
15. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
Sam S; Shon IH; Vinod SK; Lin P; Lin M
J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position.
Bird D; Patel C; Scarsbrook AF; Cosgrove V; Thomas E; Gilson D; Prestwich RJD
Radiother Oncol; 2017 Jul; 124(1):161-167. PubMed ID: 28600083
[TBL] [Abstract][Full Text] [Related]
17. First experiences of radiation treatment planning with PET/CT.
Paulsen F; Scheiderbauer J; Eschmann SM; Brechtel K; Klein M; Pfannenberg C; Mondry A; Hehr T; Belka C; Bamberg M
Strahlenther Onkol; 2006 Jul; 182(7):369-75. PubMed ID: 16826354
[TBL] [Abstract][Full Text] [Related]
18. The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer.
Mac Manus MP; Hicks RJ
Semin Nucl Med; 2012 Sep; 42(5):308-19. PubMed ID: 22840596
[TBL] [Abstract][Full Text] [Related]
19. Benefits of positron emission tomography scans for the evaluation of radiotherapy.
Decazes P; Thureau S; Modzelewski R; Damilleville-Martin M; Bohn P; Vera P
Cancer Radiother; 2020 Aug; 24(5):388-397. PubMed ID: 32448741
[TBL] [Abstract][Full Text] [Related]
20. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
